|
Volumn 110, Issue 1, 1996, Pages 72-83
|
Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: A decision analysis
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMOXICILLIN;
BISMUTH;
HISTAMINE H2 RECEPTOR ANTAGONIST;
METRONIDAZOLE;
NONSTEROID ANTIINFLAMMATORY AGENT;
OMEPRAZOLE;
TETRACYCLINE;
ADULT;
AGED;
ANTIMICROBIAL THERAPY;
ARTICLE;
BACTERIUM DETECTION;
CLINICAL TRIAL;
COST BENEFIT ANALYSIS;
DYSPEPSIA;
ENDOSCOPY;
GASTROESOPHAGEAL REFLUX;
HEALTH CARE COST;
HELICOBACTER PYLORI;
HUMAN;
LIFE EXPECTANCY;
MAINTENANCE THERAPY;
MEDICAL DECISION MAKING;
PEPTIC ULCER;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RECURRENT DISEASE;
STOMACH CANCER;
|
EID: 0030068446
PISSN: 00165085
EISSN: None
Source Type: Journal
DOI: 10.1053/gast.1996.v110.pm8536890 Document Type: Article |
Times cited : (176)
|
References (0)
|